India's No.1 Weekly For The Pharmaceutical Industry
About us || Feedback|| Advertising || Subscribe || Archives / Search 

 

Issue dated - 23rd Dec 2004

Latest News

[an error occurred while processing this directive]

News Archives >>
Toxicology studies of new antivenom completed
Is HIV drug resistance testing the need of the hour?
New technology for vitamin C production may end Chinese monopoly
Task force to evolve novel mechanisms for price monitoring
INSIDE PHARMA
IN THE NEWS
EDIT
OPED
CORPORATE
HAPPENINGS
MARKET PLACE
HEALTH NEWS
TECHNOLOGY TRENDZ
CONVERSATION
PRODUCTS
Pharma Research
(Adobe PDF file)

IN THE NEWS
EDIT
President inaugurates Sun Pharma’s advanced research centre at Vadodara
UK CRO Chiltern opens office in India
Ranbaxy, Teva sign distribution pact for Quinapril tabs
P&G Hygiene may hike product prices
Asian workshop on TRIPs ends on optimistic note

Editorial
Lost Opportunity
Close on the heels of compromises and adjustments being made by the regulator to the SSI drug units concerning Schedule-M revision, it is now the turn of the retail drug trade in Maharashtra to be the recipient of a largesse granted by the state FDA.
Edit Article
European norms for drug development

OPED
MARKET PLACE
Human resource: Future needs of pharma industry
Role of antioxidants in therapeutics
Branding begins with a name!
A ‘Brand’ is considered to be a mixture of attributes some tangible, others intangible, says U Narayana Das
HAPPENINGS
CORPORATE

Ipca receives Lifetime Achievement Award from Chemexci
Government to reintroduce Bill to tackle spurious drugs
Biocon, ICICI Lombard tie up for rural medical cover
Schott organises Pharma Symposium 2004
Dr V B Gupta appointed director of BRNCP
Bio-Rad, ICT organise workshop on chromatographic separations

NPIL acquires inhalation anaesthetic business from UK based RhodiaNicholas Piramal India Ltd.
Ranbaxy gains US FDA approval for fluoxetine capsules
Cadila to focus on cardiovascular, gastroenteritis segments
Lupin appoints Indrajit Banerjee as President - Finance and Planning
Global R&D alliances to become trend setters in India

TECHNOLOGY TRENDZ
HEALTH NEWS

Medtronic offers insulin pumps in Indian market
Microwave chemistry: A new technique in drug discovery

Build ART clinics and satellite centres in rural areas: Experts
Experts rue ministry's decision

CONVERSATION
PRODUCTS
‘Genomics may aid in development of personalised therapy’
In an exclusive interview with R BabyManoj, Dr Kalyanasundaram Subramanian, Chief Scientific Officer of Strand Genomics, talks about the facets of genomics, as a potential discipline in the area of pharmaceutical science, while sharing details of his company and its products.
Products

 


<Top of page>
ABOUT US FEEDBACK ADVERTISE SUBSCRIBE ARCHIVES
 

© Copyright 2001: Indian Express Newspapers (Bombay) Limited (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of the Indian Express Newspapers (Bombay) Limited. Site managed by BPD.